Oncolix, Inc. — Form D/A

Oncolix, Inc. of HOUSTON, TX, a company, filed a Form D amendment with the SEC on 2016-10-25. The offering totals $400K, of which $150K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2016-10-25
• Form: D/A
• Accession: 0001574061-16-000005
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $400K
• Amount sold: $150K
• Remaining: $250K
• Minimum investment: $50K
• Investors: 2
• Date of first sale: 2016-09-13
• Security types: debt
• Revenue range: No Revenues
• SEC file number: 021-271754

Issuer

• Name: Oncolix, Inc.
• CIK: 0001574061
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 14405 WALTERS ROAD, SUITE 780, HOUSTON, TX, 77014
• Phone: 281-402-3169

Officers, directors & promoters (10)

Other filings by this issuer (6)

More

• CIK 1574061 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search